Mednet Logo
HomeEndocrinologyQuestion

How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk?

3
3 Answers
Mednet Member
Mednet Member
Endocrinology · Duke Endocrinology Clinic

This is a great question with many ramifications, and I can only give an incomplete answer that includes personal opinion. First, what is the risk? The MESA Risk Score Calculator (check it out) gives a CAC percentile score as well as a 10-year risk. The 10-year risk may be low, but a high percentile...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Endocrinology · Newyork Presbyterian Columbia University Irving Medical Center

Instead of using the term metabolic syndrome, I discuss the individual components each patient has and point to the risk of each; each should be treated if not already optimized. I make the point that in view of the other risks, an LDL below 100 (or lower, depending on CAC) will result in short-term...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Endocrinology · University of Washington

Metabolic syndrome is associated with increased CV risk. The discussion regarding statin therapy for an individual will depend upon their age, family history of ASCVD, esp premature, and other risk factors like HTN, prediabetes. If the CAC score is zero, and there is statin hesitancy, one can defer ...

Register or Sign In to see full answer

How do you counsel patients with metabolic syndrome who decline statin therapy and have low coronary calcium scores regarding their long-term CVD risk? | Mednet